FDA Orange Book · active-ingredient family
Nitazoxanide
Nitazoxanide is approved as 2 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:ALINIA · NDA 021497
2
Brand (NDA)
3
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · for suspension, tablet
Generic (ANDA) products (3)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| NITAZOXANIDE | ANNORA PHARMA | ANDA 218701 | AB | Apr 15, 2025 | |
| NITAZOXANIDE | ANI PHARMS | ANDA 214844 | AB | Feb 03, 2025 | |
| NITAZOXANIDE | RISING | ANDA 213820 | AB | Nov 27, 2020 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Nitazoxanide — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

